Zimmer Biomet Holdings Stock Five Year Return
| ZIM Stock | EUR 105.00 0.45 0.43% |
Zimmer Biomet Holdings fundamentals help investors to digest information that contributes to Zimmer Biomet's financial success or failures. It also enables traders to predict the movement of Zimmer Stock. The fundamental analysis module provides a way to measure Zimmer Biomet's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Zimmer Biomet stock.
Zimmer |
Zimmer Biomet Holdings Company Five Year Return Analysis
Zimmer Biomet's Five Year Return is considered one of the best measures to evaluate fund performance, especially from the mid and long term perspective. It shows the total annualized return generated from holding equity for the last five years and represents capital appreciation of the investment, including all dividends, losses, and capital gains distributions.
More About Five Year Return | All Equity Analysis
Five Year Return | = | (Mean of Monthly Returns - 1) | X | 100% |
Current Zimmer Biomet Five Year Return | 0.72 % |
Most of Zimmer Biomet's fundamental indicators, such as Five Year Return, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Zimmer Biomet Holdings is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Although Five Year Returns can give a sense of overall investment potential, it is recommended to compare equity performance with similar assets for the same five year time interval. Similarly, comparing overall investment performance over the last five years with the appropriate market index is a great way to determine how this equity instrument will perform during unforeseen market fluctuations.
| Competition |
According to the company disclosure, Zimmer Biomet Holdings has a Five Year Return of 0.72%. This is much higher than that of the Healthcare sector and significantly higher than that of the Medical Devices industry. The five year return for all Germany stocks is notably lower than that of the firm.
Zimmer Five Year Return Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Zimmer Biomet's direct or indirect competition against its Five Year Return to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Zimmer Biomet could also be used in its relative valuation, which is a method of valuing Zimmer Biomet by comparing valuation metrics of similar companies.Zimmer Biomet is currently under evaluation in five year return category among its peers.
Zimmer Fundamentals
| Return On Equity | 0.0236 | |||
| Return On Asset | 0.0371 | |||
| Profit Margin | 0.03 % | |||
| Operating Margin | 0.19 % | |||
| Current Valuation | 29.79 B | |||
| Shares Outstanding | 210.06 M | |||
| Shares Owned By Institutions | 90.95 % | |||
| Price To Earning | 10.60 X | |||
| Price To Book | 2.15 X | |||
| Price To Sales | 3.27 X | |||
| Revenue | 6.94 B | |||
| Gross Profit | 4.92 B | |||
| EBITDA | 1.49 B | |||
| Net Income | 231.4 M | |||
| Cash And Equivalents | 403.1 M | |||
| Cash Per Share | 1.97 X | |||
| Total Debt | 5.32 B | |||
| Debt To Equity | 74.70 % | |||
| Current Ratio | 1.19 X | |||
| Book Value Per Share | 57.51 X | |||
| Cash Flow From Operations | 1.28 B | |||
| Earnings Per Share | 1.30 X | |||
| Price To Earnings To Growth | 1.06 X | |||
| Target Price | 188.04 | |||
| Number Of Employees | 18 K | |||
| Beta | 1.02 | |||
| Market Capitalization | 24.63 B | |||
| Total Asset | 21.07 B | |||
| Z Score | 2.4 | |||
| Annual Yield | 0.01 % | |||
| Five Year Return | 0.72 % | |||
| Net Asset | 21.07 B | |||
| Last Dividend Paid | 0.96 |
About Zimmer Biomet Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Zimmer Biomet Holdings's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Zimmer Biomet using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Zimmer Biomet Holdings based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Additional Information and Resources on Investing in Zimmer Stock
When determining whether Zimmer Biomet Holdings offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Zimmer Biomet's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Zimmer Biomet Holdings Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Zimmer Biomet Holdings Stock:Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Zimmer Biomet Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the CEOs Directory module to screen CEOs from public companies around the world.